Multiple Dose Study of PF-04991532 in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the safety, tolerability, pharmacokinetics (PK),
and pharmacodynamics (PD) of PF-04991532 following multiple (14 days) escalating oral doses
in patient wtih type 2 diabetes.